Key facts
- Notable investors include Plug and Play Tech Center.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Gena Health
- ·The full record, as it builds
Funding rounds
No funding rounds for Gena Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Gena Health
Developer of a clinical research infrastructure platform designed to support precision oncology decision-making. The company's platform aggregates and pre-indexes clinical trials, specialist clinics, standard and emerging therapies into a unified interface, normalizes and structures treatment data, enables patient-specific search and contextual evaluation workflows, supports documentation and sharing of curated options with patients, and reduces manual research across fragmented registries and publications, enabling oncologists and cancer patients to review credible treatment pathways efficiently and engage in transparent, collaborative decision-making without replacing clinical judgement.
- Sector
- Healthcare
- HQ
- London, United Kingdom
- Founded
- 2023
- Employees
- 5
- Website
- gena.health/
- Ownership
- Privately Held (backing)
Gena Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Gena Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Gena Health in its N-PORT filings yet. We sweep new filings monthly.